Related Experiment Videos
Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide
Suvi Rasilainen1, Jenni M Nieminen, Anna-Liisa Levonen
1Haartman Institute, Transplantation Laboratory, University of Helsinki, Haartmaninkatu 8, 00014 Helsinki, Finland. suvi.rasilainen@helsinki.fi
Aims/Hypothesis:
Oxidative damage is believed to play a key role in the process of pancreatic beta cell destruction leading to type 1 diabetes. The beta cells are sensitive to oxidative stress because their intracellular anti-oxidative defence mechanisms are weak. The defence mechanisms depend heavily on glutathione, the synthesis of which is dependent on the availability of cysteine. We investigated whether an increased amount of cysteine available could protect beta cells from oxidative damage.
Methods:
Rat insulinoma cells (RINm5F) were exposed to 50 or 100 microM hydrogen peroxide in the presence of three different cysteine concentrations (0.1, 1 and 5mM). Cell viability was analyzed by vital staining and the cellular metabolic status by C,N-diphenyl-N'-4,5-dimethyl thiazol-2-yl tetrazolium bromide (MTT) analysis. Intracellular insulin, DNA and glutathione contents were measured. The mechanism of death was further clarified by gel electrophoretic DNA fragmentation analysis.
Results:
Hydrogen peroxide decreased cell viability and induced functional impairment. Vital staining indicated that 1mM cysteine effectively protected the cells. The protective effect was confirmed by the MTT assay showing preserved metabolic integrity, and by measurements of intact intracellular insulin and DNA content. Cysteine increased intracellular glutathione. Gel electrophoretic analysis of DNA revealed hydrogen peroxide-induced apoptotic fragmentation. This was also abolished by 1mM cysteine. The therapeutic window of cysteine was narrow: 0.1mM cysteine provided inadequate protection, and 5mM cysteine was already toxic in this setting.
Conclusion:
A proper dose of cysteine could provide a safe and effective means to protect beta cells from oxidative damage.
Insights
Cysteine supplementation can protect pancreatic beta cells from oxidative damage, a key factor in type 1 diabetes. A specific concentration of cysteine effectively preserved cell viability and function, offering a potential therapeutic strategy.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Oxidative damage contributes to pancreatic beta cell destruction in type 1 diabetes.
- Beta cells possess weak antioxidant defenses, relying on glutathione, which requires cysteine for synthesis.
- Investigating cysteine's role in protecting beta cells from oxidative stress is crucial.
Purpose of the Study:
- To determine if increased cysteine availability can protect pancreatic beta cells from oxidative damage.
- To evaluate the dose-dependent effects of cysteine on cell viability and function under oxidative stress.
Main Methods:
- Rat insulinoma cells (RINm5F) were exposed to hydrogen peroxide with varying cysteine concentrations (0.1, 1, 5mM).
- Cell viability assessed via vital staining and MTT assay.
- Intracellular glutathione, insulin, DNA content, and DNA fragmentation were analyzed.
Main Results:
- Hydrogen peroxide reduced cell viability and function.
- 1mM cysteine significantly protected cells, preserving viability, metabolic status, insulin, and DNA.
- Cysteine increased intracellular glutathione levels and prevented hydrogen peroxide-induced apoptosis.
- A narrow therapeutic window for cysteine was observed; lower doses were ineffective, and higher doses were toxic.
Conclusions:
- Optimized cysteine dosage can safely and effectively protect pancreatic beta cells against oxidative damage.
- Cysteine's protective mechanism involves enhancing glutathione synthesis and mitigating apoptosis.